Spinal cord normalization in multiple sclerosis.
Spinal cord normalization in multiple sclerosis.
复制标题
DOI:
10.1111/jon.12097
复制
发表时间:
2014-11
期刊:
影响因子:
--
通讯作者:
Reich DS
中科院分区:
文献类型:
--
作者:
Oh J;Seigo M;Saidha S;Sotirchos E;Zackowski K;Chen M;Prince J;Diener-West M;Calabresi PA;Reich DS
Spinal cord(SC) pathology is common in multiple sclerosis(MS), and measures of SC-atrophy are increasingly utilized. Normalization reduces biological variation of structural measurements unrelated to disease, but optimal parameters for SC volume(SCV)-normalization remain unclear. Using a variety of normalization factors and clinical measures, we assessed the effect of SCV-normalization on detecting group differences and clarifying clinical-radiological correlations in MS. 3T cervical SC-MRI was performed in 133 MS cases and 11 healthy controls(HC). Clinical assessment included:expanded disability status scale(EDSS), MS functional composite(MSFC), quantitative hip-flexion strength(“strength”), and vibration sensation threshold(“vibration”). SCV between C3-C4 was measured and normalized individually by:subject height, SC-length, and intracranial volume(ICV). There were group differences in raw-SCV and after normalization by height and length(MS vs. HC; progressive vs. relapsing MS-subtypes, p<0.05). There were correlations between clinical measures and raw-SCV(EDSS:r=−0.20; MSFC:r=0.16; strength:r=0.35; vibration:r=−0.19). Correlations consistently strengthened with normalization by length(EDSS:r=−0.43; MSFC:r=0.33; strength:r=0.38; vibration:r=−0.40) and height(EDSS:r=−0.26; MSFC:r=0.28; strength:r=0.22; vibration:r=−0.29), but diminished with normalization by ICV(EDSS:r=−0.23; MSFC:r=−0.10; strength:r=0.23; vibration:r=−0.35). In relapsing MS, normalization by length allowed statistical detection of correlations that were not apparent with raw-SCV. SCV-normalization by length improves the ability to detect group differences, strengthens clinical-radiological correlations, and is particularly relevant in settings of subtle disease-related SC-atrophy in MS. SCV-normalization by length may enhance the clinical utility of measures of SC-atrophy.
登录
查看更多内容
DOI:
10.1177/1352458512456614
发表时间:
2013-04
期刊:
Multiple sclerosis (Houndmills, Basingstoke, England)
影响因子:
--
作者:
Oh J;Zackowski K;Chen M;Newsome S;Saidha S;Smith SA;Diener-West M;Prince J;Jones CK;Van Zijl PC;Calabresi PA;Reich DS
通讯作者:
Reich DS
影响因子:
4.4
作者:
Mann, Ranbir S.;Constantinescu, Cris S.;Tench, Christopher R.
通讯作者:
Tench, Christopher R.
影响因子:
2.4
作者:
Healy, Brian C.;Arora, Ashish;Bakshi, Rohit
通讯作者:
Bakshi, Rohit
影响因子:
2.8
作者:
Zivadinov, R;Locatelli, L;Zorzon, M
通讯作者:
Zorzon, M
影响因子:
11.2
作者:
Polman CH;Reingold SC;Banwell B;Clanet M;Cohen JA;Filippi M;Fujihara K;Havrdova E;Hutchinson M;Kappos L;Lublin FD;Montalban X;O'Connor P;Sandberg-Wollheim M;Thompson AJ;Waubant E;Weinshenker B;Wolinsky JS
通讯作者:
Wolinsky JS